Groundbreaking Cancer Treatment May Actually Raise Risk of Secondary Cancers
An illustration of chimeric antigen receptor (CAR)-T cells attacking a cancer cell.Illustration: ART-ur (Shutterstock)A relatively new cancer treatment known as CAR T cell therapy is perhaps more dangerous than we knew. The Food and Drug Administration found evidence that the treatment can potentially raise the risk of secondary cancers and is telling makers of these products to add a boxed warning detailing the risk to their labeling. However, the FDA still says that the positives of CAR T therapy outweigh the potential…